Prediction of efficacy of neoadjuvant chemotherapy for breast cancer:a comparison of multiple imaging modalities
10.16781/j.CN31-2187/R.20240704
- VernacularTitle:乳腺癌新辅助化疗后疗效的预测:多种成像方式的比较
- Author:
Dezheng SUN
1
;
Wenyan DONG
;
Min FANG
;
Fu SHEN
;
Chaoqian LIU
;
Yuan SHENG
Author Information
1. 海军军医大学(第二军医大学)第一附属医院甲乳外科,上海 200433
- Keywords:
breast neoplasms;
neoadjuvant chemotherapy;
imaging modality;
parameter index;
radiomics;
artificial intelligence
- From:
Academic Journal of Naval Medical University
2025;46(4):524-529
- CountryChina
- Language:Chinese
-
Abstract:
Imaging modalities play an important role in predicting the efficacy of neoadjuvant chemotherapy for breast cancer,and different imaging modalities have their own advantages and value.In this review,the performance of mammography,magnetic resonance imaging(MRI),ultrasound,and positron emission tomography in predicting the efficacy of neoadjuvant chemotherapy for breast cancer was compared.Among them,MRI,especially dynamic contrast-enhanced MRI,and the combination of imaging omics and artificial intelligence,has shown high sensitivity and specificity,and has gradually become the preferred examination method.With the continuous progress of technology and research,these imaging modalities are expected to play more important roles in the precise and individualized treatment of breast cancer.
